Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A molecular microbiologist, Dr Janjira’s research focusses on using bacterial typing based on genome to confirm which disease is present in a patient. She aims to develop a single whole genome sequence type test using mutliple-PCR assays that can determine from a single sample of blood what bacteria or viruses are present in a patient’s blood - thereby speeding up diagnosis and potentially saving lives in resource-limited settings.

My name is Janjira Thaipadungpanit, I am the Head of Molecular Microbiology at MORU; I do bacterial typing based on genome. We do molecular diagnosis based on real time PCR. Molecular diagnosis is an important laboratory tool: we can confirm which disease people have – something that a microbiology lab or blood culture cannot tell you.

For example, rodents carry leptospira with no symptoms, but leptospira from rat urine contaminates the environment. People acquire the leptospirosis infection by contact with the contaminated environment or by direct contact with infected animals. People at risk of leptospirosis – or melioidosis – are farmers who work daily in rice paddy fields, or fish in a pond. Leptospirosis can lead to multiple organ failure, and in a quarter of cases leads to death.

We have many infections or diseases in this region, and normally we have to do nine PCR assays per patient sample. We don't get enough blood to get all the DNA to cover all the tests that we need to do. We need to develop a test that can do mutliple-PCR that can diagnose more than one test at the same time to save time and to save the DNA or blood from patients. If we could develop a single diagnostic test based on whole genome sequence, a test that uses one sample of blood to diagnose for every virus or bacteria, that would be better. This is the challenge, and we would like to develop that.

Q: What is it like working with international scientists, people from other cultures?

Janjira Thaipadungpanit: I am really happy that I have the opportunity to work here at MORU. Scientists here have time to sit and talk to juniors. When we have questions – what do you think? – then they explain, they listen to you. I think it's a very beautiful, good environment. They don't block your brain, or say you don't think. That is what I love about MORU and all the people here.

Q: How do you feel when your research has an impact on patients?

JT: I feel that what I did is very useful. My research is useful right now for the Thai people. But when it is cited in another country, then it means that it is useful to another country's people as well. Then, for me, I think, I will be a super girl, and that I helped humanity.

Janjira Thaipadungpanit

Microbiology

Head of Molecular Microbiology at MORU, Dr Janjira Thaipadungpanit's research interests include the molecular epidemiology of leptospirosis and melioidosis using multilocus sequence typing or genome data and molecular diagnosis to identify the causes of acute febrile illness and sepsis in patients.

More podcasts related to Global Health

Dorcas Kamuya: Voices of health research ethics in Kenya

Dorcas Kamuya leads research on the ethics of emerging technologies, collaborative science, and pandemic response. Her work explores ethical frameworks for biobanking and cell line generation in Africa, addressing social acceptability, cultural norms, and equity. She advocates for proactive, context-specific ethics to ensure research is inclusive, trustworthy, and impactful in African settings.

Emelda Okiro: Transforming birth and death registration

Emelda Okiro researches how to strengthen birth and death registration systems in Kenya by identifying barriers in both the health system and communities. Her work uses surveillance data, interviews and focus groups to co-design context-specific interventions, aiming to improve real-time data, accountability, and ultimately equitable access to services and policy planning.

Kevin Marsh: Africa in partnership with Oxford

Kevin leads the Africa Oxford Initiative (AfOx), promoting equitable research, education, and innovation partnerships between African researchers and the University of Oxford. His work focuses on strengthening collaborations, expanding graduate opportunities, and supporting Africa’s knowledge-driven future. Key challenges include defining equity in partnerships and adapting to shifting global research funding landscapes.

Sassy Molyneux: Strengthening health and research systems

Health systems in LMICs face daily stresses such as resource shortages and policy changes, alongside periodic shocks such as epidemics. Enhancing resilience combined with research ethics ensures high-quality research responsive to local communities. Minimising moral distress among frontline staff in international research is crucial for sustaining quality healthcare and advancing science amid challenging conditions.

Proochista Ariana: Building capacity for global health impact

The intersection between international developments and health is complex and multidimensional. Development initiatives, such as building roads, can enhance access to healthcare, education and markets, yet may also increase risks such as accidents and disease transmission. In Liberia, we investigate factors contributing to maternal and neonatal mortality through policy analysis and community perspectives. Our Master’s in International Health and Tropical Medicine aims to foster effective solutions and capacity building in global health leadership.

Jacob McKnight: Preparing Kenya’s health system for extreme weather

In both high- and low-income countries, health systems need to be ready for extreme weather. While sustainability efforts are underway, health systems must cope with events like floods and droughts, which increase healthcare demand and disrupt services. The NEWRISK project in Kenya addresses these challenges, emphasizing resilience and insurance strategies to maintain healthcare access during crises, amid climate change's broad impacts on health systems.

Caesar Atuire: Making health more ethical for all

Ethics emphasises fair and equitable actions, particularly important in healthcare. For example, a project on solidarity highlights disparities in COVID-19 vaccine distribution, questioning ethical ideals. Major challenges include health inequalities, radical disagreements, AI responsibility and structural injustice. Our research looks at justice and equity in health interventions, ensuring they reach those in need effectively and timely.

Ben Cooper: Drug-resistant infections and disease dynamics

Infectious diseases carry a huge impact and developing interventions remains a priority. A recent trial in Southeast Asia aimed at shortening antibiotic treatment for ventilator-associated pneumonia, reducing side effects and the risk of antimicrobial resistance. Collaborations underline the global AMR burden and the need for effective solutions, from improved antibiotics use to novel diagnostics and vaccines, crucial amid rising challenges.

Rogier van Doorn: Antimicrobial resistance in Vietnam

OUCRU Hanoi runs a research program on antimicrobial resistance, focusing on the widespread resistance due to antibiotic overuse. Causing over 1.2 million deaths annually, AMR surpasses many major diseases. Our work includes community intervention trials, hospital stewardship programmes and extensive surveillance projects, aiming to inform and implement effective antibiotic use and policies globally.

Sam Kinyanjui: Building local research leadership in Africa

Over 25 years ago, research on malaria vaccine design underlined the lack of first-hand experience of the disease among scientists, and the necessity to build capacity in affected regions. In Kenya, training and support frameworks have empowered over 1,000 budding scientists since 2008, addressing the continent's research capacity gap with strategic partnerships.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.